2023 - Research.com Medicine in Netherlands Leader Award
Chris J.L.M. Meijer is conducting research in Sanger sequencing and Germline mutation as part of his Mutation study. His research combines Cervical cancer screening and Cancer. His study ties his expertise on Cervical cancer together with the subject of Cervical cancer screening. Borrowing concepts from Cervical screening, Chris J.L.M. Meijer weaves in ideas under Cervical cancer. His Internal medicine study frequently involves adjacent topics like Receiver operating characteristic. His Receiver operating characteristic study frequently draws connections to adjacent fields such as Internal medicine. Chris J.L.M. Meijer brings together Gynecology and Obstetrics to produce work in his papers. His study deals with a combination of Obstetrics and Pathology. In his works, he performs multidisciplinary study on Pathology and Colposcopy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
J. M. M. Walboomers;M. V. Jacobs;M. M. Manos;F. X. Bosch.
The Journal of Pathology (1999)
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
Nubia Muñoz;F. Xavier Bosch;Silvia de Sanjosé;Rolando Herrero.
The New England Journal of Medicine (2003)
The causal relation between human papillomavirus and cervical cancer
F X Bosch;A Lorincz;N Muñoz;C J L M Meijer.
Journal of Clinical Pathology (2002)
WHO-EORTC classification for cutaneous lymphomas.
Rein Willemze;Elaine S. Jaffe;Günter Burg;Lorenzo Cerroni.
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)
The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR.
Ana-Maria de Roda Husman;Jan M. M. Walboomers;Adriaan J. C. van den Brule;Chris J. L. M. Meijer.
Journal of General Virology (1995)
Against which human papillomavirus types shall we vaccinate and screen? The international perspective.
Nubia Muñoz;F. Xavier Bosch;Xavier Castellsagué;Mireia Díaz.
International Journal of Cancer (2004)
EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
R. Willemze;H. Kerl;W. Sterry;E. Berti.
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska.
Journal of the National Cancer Institute (2003)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco;Joakim Dillner;K Miriam Elfström;Sara Tunesi.
The Lancet (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: